Clinical Trial Update: BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study of BPN14770 in healthy adult participants completed, focusing on safety, tolerability, and pharmacokinetics for potential Al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BPN14770

Snippet

Sponsor: Tetra Discovery Partners | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED